GO:0140640 | catalytic activity, acting on a nucleic acid | 11.9% (15/126) | 3.04 | 0.0 | 0.0 |
GO:0140657 | ATP-dependent activity | 10.32% (13/126) | 3.04 | 0.0 | 1e-06 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 4.76% (6/126) | 5.41 | 0.0 | 1e-06 |
GO:0005515 | protein binding | 27.78% (35/126) | 1.34 | 0.0 | 1.1e-05 |
GO:0019222 | regulation of metabolic process | 15.87% (20/126) | 1.98 | 0.0 | 1.1e-05 |
GO:0005488 | binding | 51.59% (65/126) | 0.82 | 0.0 | 1.1e-05 |
GO:0031323 | regulation of cellular metabolic process | 15.87% (20/126) | 2.0 | 0.0 | 1.2e-05 |
GO:0032991 | protein-containing complex | 13.49% (17/126) | 2.17 | 0.0 | 1.4e-05 |
GO:0008094 | ATP-dependent activity, acting on DNA | 4.76% (6/126) | 4.34 | 1e-06 | 2.8e-05 |
GO:0060255 | regulation of macromolecule metabolic process | 15.08% (19/126) | 1.92 | 1e-06 | 3e-05 |
GO:0140097 | catalytic activity, acting on DNA | 5.56% (7/126) | 3.78 | 1e-06 | 3.6e-05 |
GO:0009889 | regulation of biosynthetic process | 14.29% (18/126) | 1.9 | 1e-06 | 4.3e-05 |
GO:0031326 | regulation of cellular biosynthetic process | 14.29% (18/126) | 1.9 | 1e-06 | 4.3e-05 |
GO:0016071 | mRNA metabolic process | 5.56% (7/126) | 3.71 | 1e-06 | 4.7e-05 |
GO:0010556 | regulation of macromolecule biosynthetic process | 14.29% (18/126) | 1.91 | 1e-06 | 4.8e-05 |
GO:0010468 | regulation of gene expression | 14.29% (18/126) | 1.91 | 1e-06 | 5.1e-05 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.38% (3/126) | 6.83 | 2e-06 | 5.2e-05 |
GO:0004386 | helicase activity | 4.76% (6/126) | 4.01 | 2e-06 | 5.4e-05 |
GO:0050794 | regulation of cellular process | 16.67% (21/126) | 1.63 | 4e-06 | 9.4e-05 |
GO:0005524 | ATP binding | 17.46% (22/126) | 1.49 | 1e-05 | 0.000214 |
GO:0050789 | regulation of biological process | 16.67% (21/126) | 1.54 | 1e-05 | 0.000223 |
GO:0016070 | RNA metabolic process | 9.52% (12/126) | 2.22 | 1.2e-05 | 0.000244 |
GO:0065007 | biological regulation | 16.67% (21/126) | 1.5 | 1.4e-05 | 0.000283 |
GO:0080090 | regulation of primary metabolic process | 12.7% (16/126) | 1.75 | 2.2e-05 | 0.000408 |
GO:0051171 | regulation of nitrogen compound metabolic process | 12.7% (16/126) | 1.76 | 2.2e-05 | 0.000411 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.38% (3/126) | 5.51 | 3.8e-05 | 0.000668 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.46% (22/126) | 1.36 | 4e-05 | 0.00068 |
GO:0090304 | nucleic acid metabolic process | 10.32% (13/126) | 1.89 | 5.3e-05 | 0.000867 |
GO:0005575 | cellular_component | 20.63% (26/126) | 1.16 | 8e-05 | 0.00126 |
GO:0008150 | biological_process | 46.83% (59/126) | 0.62 | 9e-05 | 0.001289 |
GO:0032559 | adenyl ribonucleotide binding | 17.46% (22/126) | 1.28 | 8.9e-05 | 0.001309 |
GO:0003674 | molecular_function | 62.7% (79/126) | 0.46 | 8.8e-05 | 0.00134 |
GO:0016592 | mediator complex | 2.38% (3/126) | 5.03 | 0.000107 | 0.001441 |
GO:0030015 | CCR4-NOT core complex | 1.59% (2/126) | 6.93 | 0.000106 | 0.001478 |
GO:0006402 | mRNA catabolic process | 2.38% (3/126) | 4.98 | 0.000119 | 0.001557 |
GO:0006355 | regulation of DNA-templated transcription | 11.11% (14/126) | 1.67 | 0.000134 | 0.001656 |
GO:2001141 | regulation of RNA biosynthetic process | 11.11% (14/126) | 1.67 | 0.000134 | 0.001656 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.11% (14/126) | 1.66 | 0.000145 | 0.001697 |
GO:0051252 | regulation of RNA metabolic process | 11.11% (14/126) | 1.66 | 0.000143 | 0.001729 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 11.11% (14/126) | 1.65 | 0.000155 | 0.001773 |
GO:0030554 | adenyl nucleotide binding | 17.46% (22/126) | 1.21 | 0.000182 | 0.00203 |
GO:0010629 | negative regulation of gene expression | 3.17% (4/126) | 3.82 | 0.000192 | 0.002092 |
GO:0043167 | ion binding | 25.4% (32/126) | 0.92 | 0.000231 | 0.002405 |
GO:0008270 | zinc ion binding | 7.14% (9/126) | 2.13 | 0.000231 | 0.002457 |
GO:0032555 | purine ribonucleotide binding | 17.46% (22/126) | 1.17 | 0.000277 | 0.002816 |
GO:0032553 | ribonucleotide binding | 17.46% (22/126) | 1.15 | 0.00033 | 0.003284 |
GO:0140535 | intracellular protein-containing complex | 3.97% (5/126) | 3.04 | 0.000378 | 0.003531 |
GO:0006401 | RNA catabolic process | 2.38% (3/126) | 4.41 | 0.000389 | 0.00356 |
GO:0046483 | heterocycle metabolic process | 11.11% (14/126) | 1.53 | 0.000376 | 0.00359 |
GO:0097367 | carbohydrate derivative binding | 17.46% (22/126) | 1.14 | 0.000369 | 0.0036 |
GO:0006725 | cellular aromatic compound metabolic process | 11.11% (14/126) | 1.48 | 0.000519 | 0.004665 |
GO:0006074 | (1->3)-beta-D-glucan metabolic process | 1.59% (2/126) | 5.79 | 0.000578 | 0.004729 |
GO:0006075 | (1->3)-beta-D-glucan biosynthetic process | 1.59% (2/126) | 5.79 | 0.000578 | 0.004729 |
GO:0003843 | 1,3-beta-D-glucan synthase activity | 1.59% (2/126) | 5.79 | 0.000578 | 0.004729 |
GO:0000148 | 1,3-beta-D-glucan synthase complex | 1.59% (2/126) | 5.79 | 0.000578 | 0.004729 |
GO:0017076 | purine nucleotide binding | 17.46% (22/126) | 1.1 | 0.00054 | 0.004753 |
GO:0043170 | macromolecule metabolic process | 21.43% (27/126) | 0.94 | 0.000634 | 0.005009 |
GO:1901360 | organic cyclic compound metabolic process | 11.11% (14/126) | 1.45 | 0.000632 | 0.00508 |
GO:0008186 | ATP-dependent activity, acting on RNA | 2.38% (3/126) | 4.11 | 0.00072 | 0.005499 |
GO:0003724 | RNA helicase activity | 2.38% (3/126) | 4.11 | 0.00072 | 0.005499 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.17% (4/126) | 3.18 | 0.001028 | 0.00724 |
GO:0009890 | negative regulation of biosynthetic process | 3.17% (4/126) | 3.18 | 0.001028 | 0.00724 |
GO:0031327 | negative regulation of cellular biosynthetic process | 3.17% (4/126) | 3.18 | 0.001028 | 0.00724 |
GO:0006397 | mRNA processing | 3.17% (4/126) | 3.19 | 0.000999 | 0.007383 |
GO:0016570 | histone modification | 2.38% (3/126) | 3.95 | 0.000985 | 0.007399 |
GO:0003712 | transcription coregulator activity | 2.38% (3/126) | 3.88 | 0.001138 | 0.007555 |
GO:1901265 | nucleoside phosphate binding | 17.46% (22/126) | 1.02 | 0.001126 | 0.007584 |
GO:0000166 | nucleotide binding | 17.46% (22/126) | 1.02 | 0.001126 | 0.007584 |
GO:0005694 | chromosome | 1.59% (2/126) | 5.34 | 0.001094 | 0.007594 |
GO:0043168 | anion binding | 17.46% (22/126) | 1.0 | 0.001305 | 0.008537 |
GO:1990234 | transferase complex | 3.17% (4/126) | 3.08 | 0.00134 | 0.008647 |
GO:0006338 | chromatin remodeling | 2.38% (3/126) | 3.7 | 0.001616 | 0.01014 |
GO:0031324 | negative regulation of cellular metabolic process | 3.17% (4/126) | 3.01 | 0.001596 | 0.01015 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.17% (4/126) | 2.98 | 0.001715 | 0.010471 |
GO:0009892 | negative regulation of metabolic process | 3.17% (4/126) | 2.98 | 0.001715 | 0.010471 |
GO:1901363 | heterocyclic compound binding | 17.46% (22/126) | 0.96 | 0.00189 | 0.01139 |
GO:0140513 | nuclear protein-containing complex | 3.97% (5/126) | 2.51 | 0.001944 | 0.011563 |
GO:0036094 | small molecule binding | 17.46% (22/126) | 0.95 | 0.002084 | 0.012083 |
GO:0005634 | nucleus | 4.76% (6/126) | 2.2 | 0.002063 | 0.012111 |
GO:0006325 | chromatin organization | 2.38% (3/126) | 3.55 | 0.002204 | 0.012616 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.11% (14/126) | 1.24 | 0.00252 | 0.01425 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 1.59% (2/126) | 4.73 | 0.002592 | 0.014476 |
GO:0016571 | histone methylation | 1.59% (2/126) | 4.66 | 0.002821 | 0.015202 |
GO:0034968 | histone lysine methylation | 1.59% (2/126) | 4.66 | 0.002821 | 0.015202 |
GO:0098797 | plasma membrane protein complex | 1.59% (2/126) | 4.66 | 0.002821 | 0.015202 |
GO:0000123 | histone acetyltransferase complex | 1.59% (2/126) | 4.61 | 0.00306 | 0.016297 |
GO:0004651 | polynucleotide 5'-phosphatase activity | 0.79% (1/126) | 8.25 | 0.003287 | 0.016727 |
GO:0004484 | mRNA guanylyltransferase activity | 0.79% (1/126) | 8.25 | 0.003287 | 0.016727 |
GO:0010252 | obsolete auxin homeostasis | 0.79% (1/126) | 8.25 | 0.003287 | 0.016727 |
GO:0042800 | histone H3K4 methyltransferase activity | 0.79% (1/126) | 8.25 | 0.003287 | 0.016727 |
GO:0018022 | peptidyl-lysine methylation | 1.59% (2/126) | 4.49 | 0.003565 | 0.017943 |
GO:0071824 | protein-DNA complex organization | 2.38% (3/126) | 3.28 | 0.003738 | 0.018408 |
GO:0009987 | cellular process | 28.57% (36/126) | 0.63 | 0.003698 | 0.018409 |
GO:0031248 | protein acetyltransferase complex | 1.59% (2/126) | 4.44 | 0.003831 | 0.018469 |
GO:1902493 | acetyltransferase complex | 1.59% (2/126) | 4.44 | 0.003831 | 0.018469 |
GO:0016311 | dephosphorylation | 2.38% (3/126) | 3.23 | 0.004082 | 0.019475 |
GO:0016043 | cellular component organization | 5.56% (7/126) | 1.79 | 0.004289 | 0.020249 |
GO:0048523 | negative regulation of cellular process | 3.17% (4/126) | 2.6 | 0.004463 | 0.020859 |
GO:0048519 | negative regulation of biological process | 3.17% (4/126) | 2.51 | 0.005562 | 0.025729 |
GO:0034655 | nucleobase-containing compound catabolic process | 2.38% (3/126) | 3.05 | 0.005794 | 0.026535 |
GO:0040029 | epigenetic regulation of gene expression | 1.59% (2/126) | 4.12 | 0.005941 | 0.026938 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0006370 | 7-methylguanosine mRNA capping | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0044770 | cell cycle phase transition | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:1990112 | RQC complex | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0042054 | histone methyltransferase activity | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0140938 | histone H3 methyltransferase activity | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0044772 | mitotic cell cycle phase transition | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0044843 | cell cycle G1/S phase transition | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0008192 | RNA guanylyltransferase activity | 0.79% (1/126) | 7.25 | 0.006563 | 0.02708 |
GO:0006357 | regulation of transcription by RNA polymerase II | 2.38% (3/126) | 2.95 | 0.007031 | 0.028751 |
GO:0140098 | catalytic activity, acting on RNA | 3.97% (5/126) | 2.06 | 0.007197 | 0.028914 |
GO:0006807 | nitrogen compound metabolic process | 20.63% (26/126) | 0.71 | 0.007157 | 0.029007 |
GO:0044270 | cellular nitrogen compound catabolic process | 2.38% (3/126) | 2.93 | 0.007363 | 0.029322 |
GO:0006396 | RNA processing | 3.97% (5/126) | 2.05 | 0.007442 | 0.029384 |
GO:0046700 | heterocycle catabolic process | 2.38% (3/126) | 2.92 | 0.007532 | 0.029484 |
GO:0018205 | peptidyl-lysine modification | 1.59% (2/126) | 3.93 | 0.007705 | 0.029653 |
GO:0044238 | primary metabolic process | 23.81% (30/126) | 0.64 | 0.007643 | 0.029666 |
GO:0006479 | protein methylation | 1.59% (2/126) | 3.89 | 0.008083 | 0.030343 |
GO:0008213 | protein alkylation | 1.59% (2/126) | 3.89 | 0.008083 | 0.030343 |
GO:0043933 | protein-containing complex organization | 3.17% (4/126) | 2.35 | 0.008036 | 0.030672 |
GO:0071840 | cellular component organization or biogenesis | 5.56% (7/126) | 1.61 | 0.00832 | 0.030979 |
GO:0043227 | membrane-bounded organelle | 4.76% (6/126) | 1.78 | 0.008523 | 0.031227 |
GO:0043231 | intracellular membrane-bounded organelle | 4.76% (6/126) | 1.78 | 0.008523 | 0.031227 |
GO:0009057 | macromolecule catabolic process | 3.17% (4/126) | 2.31 | 0.008999 | 0.03271 |
GO:0019903 | protein phosphatase binding | 0.79% (1/126) | 6.66 | 0.009829 | 0.034362 |
GO:0006435 | threonyl-tRNA aminoacylation | 0.79% (1/126) | 6.66 | 0.009829 | 0.034362 |
GO:0019902 | phosphatase binding | 0.79% (1/126) | 6.66 | 0.009829 | 0.034362 |
GO:0051568 | histone H3-K4 methylation | 0.79% (1/126) | 6.66 | 0.009829 | 0.034362 |
GO:0004829 | threonine-tRNA ligase activity | 0.79% (1/126) | 6.66 | 0.009829 | 0.034362 |
GO:0051274 | beta-glucan biosynthetic process | 1.59% (2/126) | 3.73 | 0.010093 | 0.035021 |
GO:0051273 | beta-glucan metabolic process | 1.59% (2/126) | 3.69 | 0.010519 | 0.036225 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0009452 | 7-methylguanosine RNA capping | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0031929 | TOR signaling | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0038201 | TOR complex | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0031931 | TORC1 complex | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0032988 | protein-RNA complex disassembly | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0036260 | RNA capping | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0000390 | spliceosomal complex disassembly | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:1905393 | plant organ formation | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0046695 | SLIK (SAGA-like) complex | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0017053 | transcription repressor complex | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0071203 | WASH complex | 0.79% (1/126) | 6.25 | 0.013083 | 0.041043 |
GO:0043226 | organelle | 6.35% (8/126) | 1.36 | 0.013416 | 0.041239 |
GO:0043229 | intracellular organelle | 6.35% (8/126) | 1.36 | 0.013416 | 0.041239 |
GO:0044237 | cellular metabolic process | 19.05% (24/126) | 0.68 | 0.013284 | 0.041389 |
GO:0046872 | metal ion binding | 10.32% (13/126) | 1.01 | 0.01266 | 0.043272 |
GO:0051169 | nuclear transport | 1.59% (2/126) | 3.47 | 0.014206 | 0.043377 |
GO:0009250 | glucan biosynthetic process | 1.59% (2/126) | 3.39 | 0.015713 | 0.047659 |
GO:0035510 | DNA dealkylation | 0.79% (1/126) | 5.93 | 0.016328 | 0.047936 |
GO:0035514 | DNA demethylase activity | 0.79% (1/126) | 5.93 | 0.016328 | 0.047936 |
GO:0006623 | protein targeting to vacuole | 0.79% (1/126) | 5.93 | 0.016328 | 0.047936 |
GO:0080111 | DNA demethylation | 0.79% (1/126) | 5.93 | 0.016328 | 0.047936 |
GO:0016887 | ATP hydrolysis activity | 3.17% (4/126) | 2.04 | 0.016543 | 0.047954 |
GO:0043169 | cation binding | 10.32% (13/126) | 0.97 | 0.01595 | 0.04806 |
GO:0019439 | aromatic compound catabolic process | 2.38% (3/126) | 2.49 | 0.016513 | 0.048171 |
GO:0004674 | protein serine/threonine kinase activity | 2.38% (3/126) | 2.48 | 0.017055 | 0.048821 |
GO:1901361 | organic cyclic compound catabolic process | 2.38% (3/126) | 2.48 | 0.017055 | 0.048821 |